In the 10-Q report, Taysha Gene Therapies disclosed its financial condition, stating that it has funded its operations ...

A Type D meeting was held with the FDA in March 2025 to discuss the potential regulatory path for OPGx-LCA5, including the ...

Obtained written alignment from the FDA on key elements of TSHA-102 pivotal Part B trial design and next steps on enabling ...

Hovione and Firstgene enter strategic collaboration to advance virus-like particle platform for liver cancer: Lisbon, Portugal Thursday, May 15, 2025, 13:00 Hrs [IST] Hovione, an ...

MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the U.S. Food and Drug Administration ...

Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research ...

GEN talked with several contract development and manufacturing organizations (CDMOs) and/or contract research organizations (CROs) about new ways they are addressing AAV manufacturing challenges.

Even after the pandemic, various new infectious diseases continue to emerge, posing ongoing viral threats that demand robust ...

(Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life Sciences, a global provider of multiomics and synthetic solutions services, and Form Bio, a leading artificial ...

BACKGROUND: Exercise improves functional outcomes in patients with diabetic cardiomyopathy (DiaCM). The molecular mechanism underlying cardiac benefits of exercise in DiaCM remains incompletely ...

Xmoor Pharma has entered into a strategic partnership with KU Leuven to support a new cell and gene therapy hub.

Even after sewage stops flowing, infectious viruses can persist for days. Scientists make disturbing discovery about viruses ...